Skip to content

Adipotide (FTPP)

Research Use Only
peptideInjection

DISCONTINUED. Experimental peptide that cuts blood supply to fat cells. Terminated due to unacceptable kidney toxicity in primates. No human trials conducted.

Key Facts

  • Classification
    Peptide — DISCONTINUED: Experimental peptide that cuts blood supply to fat cells. Terminated due to kidney toxicity.
  • Primary Benefits
    Fat Loss (4/10)
  • Administration
    Injection
  • Typical Dose
    Research protocols suggest approximately 0.01 mg/kg subq daily. Primate studies at higher doses (0.25-0.75 mg/kg) caused renal tubular injury. Keep cycles extremely short (2 weeks max) and monitor kidney function closely. Development was terminated for safety reasons -- use at your own risk.
  • Evidence Strength
    Anecdotal — 8 peer-reviewed studies referenced · Community sentiment 8/10
  • Legal Status
    Research Use Only · not prescribable in US

Quick Facts

From price
$85
Type
peptide
Administration
Injection
Evidence
anecdotal
Studies referenced
8
Community sentiment
8/10
Stacks with
0 peptides
Regulatory
Research Use Only

Top benefits

🔥 Fat Loss
4/10
View PricingCompare

Dosing

Research protocols suggest approximately 0.01 mg/kg subq daily. Primate studies at higher doses (0.25-0.75 mg/kg) caused renal tubular injury. Keep cycles extremely short (2 weeks max) and monitor kidney function closely. Development was terminated for safety reasons -- use at your own risk.

Benefit Profile

🔥 Fat Loss
4/10
Medical oversight requiredNot safe during pregnancy· 5 contraindications